Free Trial

Hillstream BioPharma (HILS) SEC Filings & 10K Form

Hillstream BioPharma logo
$2.50 +0.07 (+2.88%)
(As of 11/20/2024 ET)

Recent Hillstream BioPharma SEC Filings

DateFilerForm TypeView
11/13/2024
4:06 PM
Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
4:22 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2024
3:15 PM
MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
8:58 AM
Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4/A
10/08/2024
3:10 PM
Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
9:00 AM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
8:06 AM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
4:17 PM
MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:17 PM
Bui Lynne A. (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:18 PM
Mazur Leonard L (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:18 PM
Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:18 PM
Anderson Kelly (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
2:09 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/23/2024
3:13 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 424B3
07/21/2024
11:15 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form EFFECT
07/15/2024
3:43 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/28/2024
4:25 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
06/20/2024
3:15 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
3:14 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/07/2024
4:21 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 424B5
06/07/2024
4:23 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
3:15 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:30 AM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/22/2024
10:12 AM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form DEFA14A
03/22/2024
10:08 AM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form ARS
03/21/2024
4:25 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form DEF 14A
03/21/2024
4:27 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form DEFA14A
03/11/2024
3:30 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form PRE 14A
03/11/2024
3:15 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
7:30 AM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/18/2023
9:04 AM
MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
3:15 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
5:15 AM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K/A
12/08/2023
6:31 AM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
7:13 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
3:15 PM
MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
11:15 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:HILS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners